This medication is used to help prevent migraine. It is also used to treat a certain type of headache (episodic cluster headache). Galcanezumab-gnlm belongs to a class of drugs known as monoclonal antibodies. This medication may work by changing the amounts of certain natural substances in the brain. Using this medication can help improve your ability to concentrate and do your usual tasks. Galcanezumab-Gnlm Pen Injector – GENERIC NAME: GALCANEZUMAB-GNLM
Are you looking for or in search of FDA approved “galcanezumab-gnlm injection in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Migraine treatment. Need Access of galcanezumab-gnlm injection, get in touch with our healthcare professional.
Galcanezumab, sold under the brand name Emgality, is a humanized monoclonal antibody used for the prevention of migraine. It is also used for cluster headaches.
This drug was developed by Eli Lilly. It was approved for medical use in the United States and in the European Union in 2018, becoming the third calcitonin gene-related peptide (CGRP) inhibitor to do so. In September 2018, galcanezumab-gnlm was approved in the United States for the preventive treatment of migraine in adults. In November 2018, galcanezumab was approved for use in the European Union for the prophylaxis of migraine in adults who have at least four migraine days per month. In June 2019, galcanezumab-gnlm was approved in the United States for the treatment of episodic cluster headache in adults.